Dive into the archives.
- Hot off the ENS Press…Rebif Autoinject Improves SC Delivery
MILAN, Italy
June 26, 2009
A new electronic, multidose, autoinjection device improves subcutaneous delivery of interferon beta (IFNB)-1a in patients with relapsing multiple sclerosis (MS), according to a study presented here at the 19th Meeting of the European Neurological Society (ENS2009).
Virginia Devonshire, MD, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, presented [...]
- The Age of Orals: Who Will Win the Race to the Market?
Jan 23, 2009
Oral Cladribine Reduces MS Relapses in Phase 3 Clinical Trial
Oral cladribine (EMD Serono) reduced the relapse rate significantly more than inactive placebo in the phase 3 “CLARITY” study of 1,326 people with relapsing-remitting MS. These initial results – the first from any phase 3 study of oral therapy for MS — are reported [...]
